Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria
C. Mircea S. Tesileanu(Erasmus MC), Martin J. van den Bent(Erasmus MC Cancer Institute), Arnaud J.P.E. Vincent(Erasmus MC Cancer Institute), Sjoerd G. van Duinen(Leiden University Medical Center), Maarten M.J. Wijnenga(Erasmus MC), Pim J. French(Ontario Institute for Cancer Research), Linda Dirven(Leiden University Medical Center), Marion Smits(Erasmus MC), Martin Taphoorn(Leiden University Medical Center), Johan M. Kros(Erasmus MC), Hendrikus J. Dubbink(Erasmus MC), Peggy N. Atmodimedjo(Erasmus MC Cancer Institute), Johan A F Koekkoek(Leiden University Medical Center)
Cited by 213
Related Papers
Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia
|Magnetic Resonance in Medicine|2014|2.2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k